Pharmaceuticals
10 Johnson & Johnson marketing leaders
These ten current and former Johnson & Johnson marketing leaders have held director-level and higher marketing roles across Johnson & Johnson Innovative Medicine and Johnson & Johnson MedTech, including vice presidents of immunology, pulmonary hypertension, biosurgery and metabolism marketing. A reader can learn how J&J runs brand marketing and launches in areas such as immunology, oncology, neuroscience and biosurgery.
Professionals to explore
01—10Alison James
LinkedInExperience: Vice President Global Marketing - Biosurgery · Johnson & Johnson MedTech
Vice President Global Marketing - Biosurgery at Johnson & Johnson MedTech since August 2026, alongside Senior Director of US Marketing, ETHICON at Johnson & Johnson since 2024 and a Business Unit Director role at Johnson & Johnson listed since 2014. Alison James was EMEA Marketing Manager at Johnson & Johnson (2012–2014).
Candice Long
LinkedInExperience: Vice President, Immunology Marketing · Johnson & Johnson Innovative Medicine
Former Vice President, Immunology Marketing at Johnson & Johnson Innovative Medicine (2016–2020), and Worldwide VP, Immunology, Global Strategic Commercial Organization there since 2023; the profile says Candice Long leads global commercial efforts to build and maximize the value of Janssen's Immunology portfolio and pipeline. Candice Long was President, Janssen U.S. Infectious Diseases & Vaccines (2020–2022).
Heidi McNeill
LinkedInExperience: Head of Marketing (Genito-urinary Oncology) · Johnson & Johnson Innovative Medicine
Head of Marketing (Genito-urinary Oncology) at Johnson & Johnson Innovative Medicine since May 2024, following Senior Product Manager - Prostate Cancer portfolio at The Janssen Pharmaceutical Companies of Johnson & Johnson (2018–2024). Heidi McNeill was Marketing Manager at Shield Therapeutics plc (2017–2018) and Marketing Manager - CNS at Otsuka Pharmaceuticals (UK) Ltd, Uxbridge (2012–2016).
Jessica Phaup
LinkedInExperience: Head of Icotrokinra I Director of Marketing · Johnson & Johnson
Head of Icotrokinra I Director of Marketing at Johnson & Johnson since June 2025; the profile says Jessica Phaup is US launch lead and P&L owner for icotrokinra, a targeted oral peptide across a number of immune-mediated diseases. Jessica Phaup was Franchise Head, ANDEXXA and Acute Care Sales at AstraZeneca (2021–2025).
Karen Meagher
LinkedInExperience: Marketing Director Neuroscience · Johnson & Johnson Innovative Medicine
Marketing Director Neuroscience at Johnson & Johnson Innovative Medicine since 2023, and lists Marketing Director, Neuroscience and Vaccines at The Janssen Pharmaceutical Companies of Johnson & Johnson since 2021. Karen Meagher was Marketing Director, IBD (2019–2021) and Marketing Manager Dermatology (2015–2019) at Janssen.
Kate Hensman
LinkedInExperience: Senior Director of Marketing, US Prostate Portfolio · Johnson & Johnson Innovative Medicine
Senior Director of Marketing, US Prostate Portfolio at Johnson & Johnson Innovative Medicine since September 2024, following Business Unit Director, Immunology Canada (2023–2024) and Business Unit Director, Rheumatology & Dermatology Canada (2022–2023). Kate Hensman was Business Unit Director Rare Disease, ANZ (2020–2022) and Marketing Lead Rare Disease ANZ (2020) at Johnson & Johnson Innovative Medicine.
Priscilla Bottmann
LinkedInExperience: Vice President, Marketing & Sales, Pulmonary Hypertension · Johnson & Johnson Innovative Medicine
Vice President, Marketing & Sales, Pulmonary Hypertension at Johnson & Johnson Innovative Medicine since September 2024. The profile headline also describes Priscilla Bottmann as U.S. Vice President, Marketing, Franchise Strategy & Key Account Management, Neuroscience at Johnson & Johnson Innovative Medicine.
Sarah Brennan
LinkedInExperience: Vice President, Sales & Marketing Metabolism · Johnson & Johnson Innovative Medicine
Former Vice President, Sales & Marketing Metabolism (2016–2018) and Director of Marketing, Bapineuzumab (2011–2012) at Johnson & Johnson Innovative Medicine. Sarah Brennan has been Company Group Chairman, Global Commercial Strategy Organization there since 2024, a role the profile describes as shaping a portfolio of medicines, and also lists Head, Commercial Strategy & Operations since 2021.
Susanne Cullmann
LinkedInExperience: US Group Product Director, HCP Marketing and Launch Lead, GI Tremfya · Johnson & Johnson Innovative Medicine
US Group Product Director, HCP Marketing and Launch Lead, GI Tremfya at Johnson & Johnson Innovative Medicine since 2022; the profile says Susanne Cullmann led the launch of Tremfya in the IBD category on the HCP marketing side. Susanne Cullmann was Global Director HCP & Consumer, Multiple Sclerosis Ponvory (2020–2022) and Global Marketing Director, Cough & Cold Tylenol Cold, Sudafed (2016–2020) at Johnson & Johnson.
Tom Mickelson
LinkedInExperience: Head of US Dermatology Marketing · Johnson & Johnson Innovative Medicine
Former Head of US Dermatology Marketing at Johnson & Johnson Innovative Medicine (2021–2023), followed by Vice President, Global Commercial Lead - Dermatology & Rheumatology (2023–2024) and Vice President, Global Commercial Lead - Autoantibody & Rheumatology Portfolio since 2024. Tom Mickelson was US Immunology Marketing Leader (2019–2021) and US Pain Marketing Leader (2018–2019) at Eli Lilly and Company.
Choose the right perspective
Match the person's business and therapeutic area to your question, since marketing a prescription medicine and marketing a surgical product reach different customers. Check whether the person's marketing role is current or past, because several have since moved into broader commercial jobs.
Questions to take into the conversation
- 01How do you plan the marketing for a launch in a crowded therapeutic category?
- 02How do global and US marketing teams divide brand strategy and execution?
- 03How do you decide the balance between marketing to physicians and marketing to patients for a brand?
Reaching Johnson & Johnson marketing leaders
How can I contact one of these Johnson & Johnson marketing leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 3 companies: Johnson & Johnson MedTech, Johnson & Johnson Innovative Medicine and Johnson & Johnson, based on profile data retrieved on October 3, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Johnson & Johnson marketing leaders?
You choose the offer, starting at $5 per person. It includes Instant Expert's 20% fee, so an offer that pays the person $100 costs you $125. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal